Industry: Healthcare
Published Date: February-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 217
Report ID: PMRREP34027
The global endocavity transducer market is forecast to expand at a CAGR of 4.2% and thereby increase from a value of US$5.1 Bn in 2023, to US$6.8 Bn by the end of 2030.
|
Attributes |
Key Insights |
|
Endocavity Transducer Market Size (2023E) |
US$5.1 Bn |
|
Projected Market Value (2030F) |
US$6.8 Bn |
|
Global Market Growth Rate (CAGR 2023 to 2030) |
4.2% |
|
Historical Market Growth Rate (CAGR 2018 to 2022) |
3.0% |
An endocavity transducer is a medical device designed to utilize ultrasonic sound waves for imaging internal regions, specifically the colorectal and transvaginal areas. It is inserted into bodily cavities to diagnose issues within these organs, combining a sensor and actuator in a single unit. Functioning by converting electrical signals into ultrasonic energy, endocavity transducers emit sound waves into tissues and capture the reflected energy to create diagnostic images. A matching coating on the transducer's tip enhances energy transmission efficiency to the patient.
Distinguished from other imaging technologies like MRI, and standard X-rays, endocavity transducers provide real-time ultrasound images during surgical procedures. This capability aids surgeons in visualizing patient anatomy, leading to more efficient and less intrusive treatments. The precision of the endocavity transducer makes it a valuable tool in various surgical and diagnostic applications, reducing discomfort for patients.
Rising Demand for Minimally Invasive Therapies
The substantial growth of the market can be attributed to an increasing demand for minimally invasive treatments and the rising prevalence of cardiovascular, respiratory, and abdominal disorders. A study conducted by Karoline Freeman et al., published in BMC Gastroenterology Journal in March 2021, revealed a global incidence of 69.5 cases of inflammatory bowel disease (IBD) per 100,000 population.
Another study published in BMC Medicine in February 2022 highlighted the common occurrence of meal-related stomach pain worldwide, indicating its association with various gastrointestinal (GI) and non-GI symptoms, psychological distress, healthcare utilization, and lower quality of life. Individuals experiencing frequent meal-related stomach pain are more likely to meet the diagnostic criteria for disorders of gut-brain interaction (DGBI). The increasing prevalence of abdominal conditions underscores the importance of ultrasound diagnosis, driving market growth with a higher adoption of endocavity transducers.
Scarcity of Qualified Individuals
The adoption of these specialized medical devices is constrained in resource-limited settings due to their high cost. Additionally, the intricate nature of endocavity imaging techniques necessitates skilled operators and trained personnel. The endocavity transducer sector encounters competition from alternative imaging modalities. Challenges related to patient discomfort and safety, along with stringent regulatory requirements, add to the obstacles. Furthermore, the continuous evolution of technology demands ongoing investments in research and development.
Availability of Alternative Imaging Modalities
While endocavity transducers provide several advantages, there are alternative imaging modalities like magnetic resonance imaging (MRI) and computed tomography (CT) scans. The existence of these alternatives may somewhat limit the expansion of the endocavity transducer market. The operation of endo-cavity transducers demands specialized training and expertise. A shortage of skilled healthcare professionals proficient in utilizing these devices can hinder market growth, especially in regions grappling with a healthcare workforce shortage.
Rapid Advancements in Ultrasound Imaging Technology
The swift progress in ultrasound imaging technology, incorporating features like artificial intelligence (AI) and machine learning algorithms, offers substantial prospects for the endocavity transducer market. These technologies have the potential to improve the precision and effectiveness of diagnoses, creating new pathways for market expansion.
The use of endocavity transducers extends beyond urology and gynecology. A noticeable trend is emerging in employing these devices in various medical specialties, including gastroenterology and oncology. The broadening of application areas expands the market's scope and introduces fresh growth possibilities.
The market is anticipated to undergo substantial expansion and change. Companies operating in the endocavity transducer market need to prioritize research and development efforts to stay at the forefront of technological advancements. Investing in innovative features and integrating AI, and machine learning algorithms can enhance the competitiveness of their products. The untapped potential in emerging markets, particularly in Asia Pacific, and Latin America, presents significant growth opportunities.
Companies should strategically expand their presence in these regions through partnerships, distribution agreements, and localized marketing efforts. To address the shortage of skilled healthcare professionals proficient in using endocavity transducers, companies should invest in training programs and educational initiatives. This will ensure the proper utilization of their products and support the overall growth of the market.
Supply-side Dynamics
Several factors, including Increased operator comfort, sensitivity, simple equipment sterilization, and decreased noise in recently developed transducers, all contribute to the dynamic and rapid expansion of the global Endocavity Transducer market. Providian Medical, Philips Healthcare, GE Healthcare, Mindray ZONARE, and Toshiba Medical Systems are market leaders in the manufacturing sector. The countries of Germany, Japan, China, France, and the US are significant producers of various goods.
The US is anticipated to dominate the revenue share due to increased awareness of endocavity transducer devices, growing acceptance of novel products, and increased infrastructure investment to support medical and healthcare growth. In China, the market's expansion for endocavity transducers is driven by the rising prevalence of chronic diseases, such as prostate cancer and gynecological disorders. Additionally, key endocavity transducer manufacturers in the region are investing in research and development to introduce innovative and efficient endocavity transducers.
Several corporations are concentrating on research and development activities to create wireless ultrasound transducers with security alarms, a move expected to boost market growth. It is anticipated that these expansions will substantially alter the dynamics of the market, resulting in heightened competition, reduced prices, and an influx of innovative products.
Which is the Dominant Application Category?
Gynecology Applications Remain at the Forefront
The gynecology segment plays a substantial role in the endocavity transducer market. Specifically tailored for gynecological imaging, endocavity transducers provide comprehensive visualization of pelvic organs, facilitating the identification and treatment of diverse gynecological conditions, including ovarian cysts, uterine fibroids, and endometriosis.
What is the Key Product Type Segment?
The Linear Transducer Category Continues to Hold a Commanding Share
This transducer is well-suited for visualizing external structures and vessels, earning it the designation of vascular probes. It features a rectangular beam shape with excellent near-field resolution. The choice of footprint, frequency, and application is contingent on whether it is employed for 2D or 3D imaging. The 2D imaging linear transducer is extensively utilized in vascular examinations, venipuncture, blood vessel visualization, and intraoperative procedures. Conversely, 3D imaging linear transducers find application in imaging the thyroid, breast, and carotid arteries.
Which of the End User Segments Contributes the Largest Share?
Hospital to Dominate Global Market
The hospital segment is expected to take the lead in the market due to the widespread adoption of ultrasound systems as the primary imaging choice. The availability of portable ultrasound systems and their utilization in various departments are projected to drive the demand for ultrasound transducers. The increasing presence of healthcare facilities in emerging economies is a significant factor driving the demand for ultrasound transducers. The growth of the segment is also influenced by the rising number of skilled professionals in hospitals and increasing awareness about innovative devices.
North America’s Lead Intact as Chronic Disease Burden Grows Substantially High
North America is poised to capture a significant market share in the global ultrasound transducer market, driven by factors such as the increasing prevalence of chronic diseases, robust demand for technologically advanced medical devices, substantial research and development investments, a growing preference for early diagnosis among patients, and a rising need for ultrasound systems.
According to 2022 data from the American Heart Association, the prevalence of heart failure in the US reached 6 million, constituting 1.8% of the total population in 2021. The substantial burden of heart failure cases in the country is expected to drive the demand for ultrasound transducer devices, facilitating enhanced diagnosis and treatment, and contributing to the market's growth over the forecast period.
Pacing Advancements in Healthcare Facilities Uplift Performance of Asia Pacific
The Asia Pacific region is poised for substantial growth in the coming years, driven by factors such as the rapidly expanding geriatric population, advancements in healthcare facilities for addressing heart disorders, and an increasing healthcare expenditure. The flourishing medical tourism industry in economies across the Asia Pacific is also anticipated to propel the ultrasound transducer market in the region. The robust growth of medical tourism in developing nations like India, Thailand, Brazil, Mexico, and the Philippines is generating heightened demand for high-quality healthcare services. This surge in demand is expected to drive the importation of ultrasound devices into these countries. Major market players are strategically positioning themselves to enhance their presence in these regions and offer competitive pricing for their products.
Prominent organizations, including Providian Medical, Philips Healthcare, and GE Healthcare, are at the vanguard of this sector, providing inventive solutions by capitalizing on their expertise and advanced technologies in the Medical industry. Organizations operating within this sector prioritize technological advancements, strategic alliances, and user experience improvement. These businesses make substantial R&D investments to introduce innovative and efficient endocavity transducers.
To distinguish themselves in this highly competitive market, these businesses strive to differentiate their products. They achieve this by providing distinctive attributes, enhanced precision, and more extensive health observations.
New Product Launch
In August 2022, Toshiba Electronic Devices & Storage Corporation ("Toshiba") launched a new series of power devices, the "TWxxNxxxC series," featuring 3rd generation silicon carbide (SiC) MOSFETs characterized by low on-resistance and significantly reduced switching loss.
Market Impact: The Endocavity Transducer Market is expected to be driven by the launch of Toshiba's new "TWxxNxxxC series," which has 3rd generation silicon carbide (SiC) MOSFETs with low on-resistance and decreased switching loss. By providing cutting-edge technical solutions, the novel power devices are anticipated to improve the performance and efficiency of endo-cavity transducers and support the market's expansion.
In August 2022, during the European Society of Cardiology (ESC) Congress, Philips, a leading global health technology company, unveiled its latest integrated cardiology solutions. These cutting-edge advancements in cardiology aim to provide enhanced clinical insights, boost clinician confidence, optimize efficiency in critical care, and enhance the overall cardiac care journey from diagnosis to home care.
Market Impact: These integrated cardiology systems provide better clinical knowledge, more self-assurance for clinicians, greater cardiac care experiences, and increased critical care efficiency. Modern medical equipment like endocavity transducers are in high demand as healthcare practitioners look to use the newest technologies for thorough cardiovascular diagnoses and treatment. This will drive market expansion.
|
Attribute |
Details |
|
Forecast Period |
2023 to 2030 |
|
Historical Data Available for |
2018 to 2022 |
|
Market Analysis |
US$ Million for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Report Coverage |
|
|
Customization & Pricing |
Available upon request |
By Product Type:
By Application:
By End User:
By Region:
To know more about delivery timeline for this report Contact Sales
The market is anticipated to grow at a CAGR of 4.2% during the projected period.
The endocavity transducer market was valued at US$5.1 billion in 2023.
The US held the largest market share in 2023.
Some of the prominent players in the market include Providian Medical, Philips Healthcare, GE Healthcare, Mindray ZONARE, and Toshiba Medical Systems.
The linear segment is expected to grow at the fastest CAGR during the forecast period.
